Chronic disease management platform Omada Health (OMDA.US) has an IPO price of 18-20 US dollars/share and plans to raise 150 million US dollars

The Zhitong Finance App learned that Omada Health (OMDA.US), a digital healthcare company headquartered in San Francisco, California, announced the specific terms of its initial public offering (IPO) on Thursday. The company mainly provides digital health management tools for patients with chronic diseases.

According to the prospectus, Omada plans to issue 7.9 million shares at a price of 18 to 20 US dollars each, and is expected to raise a total of 150 million US dollars. Based on the median issue price range, the company's fully diluted market value will reach 1.2 billion US dollars.

Omada launched an initial diabetes prevention and weight health management program in 2012, and has now formed a diversified service matrix: cardiometabolic health management programs for pre-diabetes, diabetes, and high blood pressure; musculoskeletal disease (MSK) physical therapy programs; GLP-1 agonist treatment tracking systems; and behavioral health support services covering all programs. As of March 31, 2025, Omada has served more than one million users. Currently, it has more than 2,000 customers, and 679,000 members are participating in one or more of its health management projects.

Omada was founded in 2011, with revenue of US$190 million for the 12 months ending March 31, 2025. The company plans to list on the NASDAQ under the stock symbol OMDA. Morgan Stanley, Goldman Sachs, J.P. Morgan Chase, Barclays Bank, and Evercore ISI acted as joint bookkeepers for the transaction, and the issue price is expected to be determined during the week of June 2, 2025.